Skip to main content
    C

    CDT Equity Inc. (CDT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.38
    -0.02 (-5.84%)

    Market Cap: $407,550

    Last updated: Nov 17, 2026 at 11:04 AM ET

    CDT Equity Inc. (CDT) Financials: Revenue, Profit and Cash Flow

    Updated Jul 2, 2026. Financial statements from company filings, amounts in US dollars.

    CDT Equity reported revenue of $2.72B for the fiscal year ended Dec 31, 2025, up 194.4% from the year before. That year, net income was -$39.22M with a net margin of -1.4%, operating cash flow was -$15.55M and free cash flow was -$17.96M. The quarter ended Jun 30, 2026 had revenue of $750.16M and net income of $68.54M.

    Revenue and Margins

    The operating margin was -1.4% in the fiscal year ended Dec 2025.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$2.72B+194.4%38.0%-1.4%-1.4%
    Dec 2024$922.22MN/A0.0%-1.7%-1.9%
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2021 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Revenue$2.72B$922.22M$0$0$0
    Cost of revenue$1.68B$457.00KN/AN/AN/A
    Gross profit$1.03B-$457.00KN/AN/AN/A
    Research and development$5.05M$3.38M$90.00K$111.00K$283.00K
    Operating income-$36.76M-$15.42M-$5.26M-$3.16M-$3.17M
    Net income-$39.22M-$17.80M-$535.00K-$4.89M-$3.66M
    EBITDA-$36.48MN/A$3.05MN/AN/A
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$750.16M$696.38M$2.72B$698.22M$671.99M$624.86M$1.08B$654.93M-$1.35B$535.67M$0$0
    Gross profit$301.03M$258.09M-$515.00K-$885.00K-$828.00K-$190.00K-$452.00K-$5.00K-$695.87M$201.60MN/AN/A
    Operating income$117.37M$77.96M-$21.16M-$7.03M-$4.95M-$3.62M-$3.51M-$5.81M-$3.14M-$2.96M-$895.00K-$430.00K
    Net income$68.54M$51.03M-$21.32M-$7.12M-$6.03M-$4.75M-$2.41M-$6.46M-$5.38M-$3.55M$1.78M$2.63M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents of $389.89M were 11.0% of total assets of $3.54B, against total liabilities of $2.28B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Total assets$3.54B$4.19M$7.22M$5.00K$213.13K
    Current assets$1.35B$2.71M$5.73M$646.64K$104.16K
    Cash and equivalents$389.89M$554.00K$4.23M$345.78K$48.55K
    Total liabilities$2.28B$10.99M$7.68M$10.09M$192.51K
    Short-term debtN/A$7.35M$985.00K$175.00K$177.06K
    Long-term debtN/AN/AN/A$2.01M$749.00K
    Shareholder equity$1.26B-$6.79M-$457.00K-$10.09M$20.62K
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$3.50B$3.46B$3.54B$8.55M$7.99M$7.32M$4.19M$2.99M$3.31M$4.92M$7.22M$12.02M
    Total liabilities$2.12B$2.18B$2.28B$4.27M$4.46M$4.63M$10.99M$12.11M$8.77M$8.02M$7.68M$13.10M
    Cash and equivalents$348.65M$272.15M$389.89M$3.84M$3.33M$2.13M$554.00K$71.00K$219.00K$1.84M$4.23M$8.64M
    Shareholder equity$1.38B$1.28B$1.26B$4.28M$3.53M$2.69M-$6.79M-$9.12M-$5.46M-$3.10M-$457.00K-$1.08M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Operating cash flow-$15.55M-$9.68M-$7.72M-$2.27M-$2.15M
    Capital expenditures$2.40M$51.00K$0$0$5
    Free cash flow-$17.96M-$9.73M-$7.72M-$2.27M-$2.15M
    Dividends paid$7.97M$8.20MN/AN/AN/A
    Investing cash flow-$808.00K-$43.00K$725.00K-$183.00K$48.55K
    Financing cash flow$17.42M$6.07M$10.93M$2.45M$1.90M
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow$42.74M-$18.67M-$4.64M$105.01M-$2.58M$7.44M-$3.81M-$2.00M-$1.51M-$2.36M-$4.80M-$524.00K
    Capital expenditures$40.66M$44.39M$1.00M$39.68M$1.00K$32.20M$80.33M$41.00K$10.00K$24.25M$0$0
    Free cash flow$2.08M-$63.06M-$5.64M$65.33M-$2.58M-$24.76M-$84.14M-$2.04M-$1.52M-$26.61M-$4.80M-$524.00K
    Last 12 quarters

    Frequently Asked Questions About CDT

    What is CDT Equity's annual revenue?

    CDT Equity reported revenue of $2.72B for the fiscal year ended Dec 31, 2025.

    How fast is CDT Equity's revenue growing?

    Revenue was up 194.4% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is CDT Equity profitable?

    No. CDT Equity reported net income of -$39.22M for the fiscal year ended Dec 31, 2025, with a net margin of -1.4%.

    How much free cash flow does CDT generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$15.55M minus capital expenditures of $2.40M produced free cash flow of -$17.96M.

    How much debt does CDT Equity have?

    The balance sheet dated Dec 31, 2025 reported cash and equivalents of $389.89M.